Clinical Trial Update: A Drug Interaction Study of VI-0521 With Metformin, Sitagliptan and Probenecid in Healthy Subjects. [Phase 1]

View source ↗

Summary

Phase 1 study evaluating potential drug interactions between VI-0521 and metformin, sitagliptin, and probenecid in healthy subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Probenecid (probenecid)
• Sitagliptin (sitagliptin)
• VI-0521
• metformin (metformin)

Snippet

Sponsor: VIVUS LLC | Conditions: Obesity | Phase 1 | Status: COMPLETED